Lilly, Novo Nordisk closer to deal with Trump administration to slash obesity drug prices to $149/month
The discussions come as part of the administration’s broader efforts to drive down drug prices and increase patient access to essential therapies
The discussions come as part of the administration’s broader efforts to drive down drug prices and increase patient access to essential therapies
Subscribe To Our Newsletter & Stay Updated